chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recv vax 21JUN96 & 22JUN96 pt devel a fever which lasted for 10 days;
Patient passed out in chair in waiting area. Was treated in the room for sinus brady and nausea. 18 g IV established 1 mg atropine and 4mg Zofran administered. Pt. started to "Feel Better". Not sinus rhythm and nausea subsided. Pt. transported to the hospital via Ambulance for further treatment if needed and monitoring.
I had a ringing in my ears I noticed as soon as I got quiet . I have had 2 more vaccines of Pfizer covid and the ringing has gotten stronger  yesterday I had Moderna booster and thought this should be documented  . I?ve reached out before but with no follow up .
Moderna Booster administered to person under the age of 18. Patient was 17 years 2 months old at time Moderna Booster administered. No reaction or negative outcome noted.
3/31/21 26YM admit with Acute issue: myocarditis, chest pain, extreme fatigue, body aches, SOB; Moderna (first dose on 3/28). No known prior COVID.  Patient admits that approximately a month and a half ago, he was drinking a significant amount of alcohol with a 24-pack of beer daily and 5 drinks at night.  He quit this approximately 2 weeks ago when he got back together with his girlfriend.  He has had stress in his life with the death of a cousin approximately 2 weeks ago.  The patient had been feeling well over the last week or so and received the Moderna COVID-19 vaccine on 3/28 Sunday.  This was his first dose.  Approximately an hour and a half after receiving the vaccine, he had symptoms of feeling dizzy with position change.  He went home from work.  He developed fevers, chills, rigors, diaphoresis, and headaches.  He slept a lot due to these symptoms.  On 3/30 Tuesday, he woke with mild chest discomfort that he described as a pressure sensation in his anterior chest.  He states that it was bothersome, but not too significant.  He woke up 3/31 at approximately 0200 hours with a stabbing left anterior chest discomfort.  He notes that it felt like a hot knife stabbing him.  He admits that over the last couple of days, he had a cough when he would lay back in bed.  He admits to feeling more short of breath when flat and feeling like he had to put pillows behind his head.  He came to the emergency department due to these symptoms.  He was given a dose of acetaminophen and promptly had nausea and vomiting.  He received a dose of aspirin 325 mg and states that his symptoms resolved shortly after that.  3/31 He now feels well and denies any further chest discomfort.  He denies any dyspnea.
Information has been received from a licensed practical for the pregnancy registry for GARDASIL vaccine (yeast) concerning a 27 year old female with no pertinent medical history and no allergies who on 28-DEC-2007 was vaccinated with the first dose of GARDASIL vaccine (yeast) (lot # 659653/1448U). On 28-FEB-2008 the patient was vaccinated with the second dose of GARDASIL vaccine (yeast) (lot # 659655/1486U). On 26-JUN-2008 the patient was vaccinated with the third dose of GARDASIL vaccine (yeast) (lot # 660555/0279X). There was no concomitant medication. The patient became pregnant during the immunization schedule of vaccine. The "ultrascreen and blood test" were performed. The last menstrual period was 16-JUN-2008. The estimated due date is 23-MAR- 2009. Date of conception was three days before receiving the third dose. No adverse effects were reported. Additional information has been requested.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Mar2021 as dose 1, single (Lot number: EN6204), in left arm, on 08Apr2021 as dose 2, single (Lot number: EW0162), in left arm and on 14Oct2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 42 years, in left arm for covid-19 immunisation.  The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing); "postpartum anxiety" (unspecified if ongoing); "vitamin D deficiency" (unspecified if ongoing), notes: ,; "seasonal allergies" (unspecified if ongoing); "asthma" (unspecified if ongoing). Concomitant medication(s) included: METHOTREXATE; INFLECTRA [INFLIXIMAB]; VITAMIN D2; CLARITIN [CLARITHROMYCIN]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ALEVE; VENLAFAXINE. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 07May2022, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07May2022) Positive; (13May2022) Negative, notes: Home tests; (15May2022) Negative, notes: Home tests; (16May2022) Negative, notes: Home tests; (27May2022) Positive, notes: Home tests; (27May2022) Positive, notes: Home tests. Therapeutic measures were taken as a result of vaccination failure, covid-19. Additional information: Known allergies: No. Recurrence of COVID - initially tested positive on 07May2022. Treated with Paxlovid for 5 days and then tested negative with 2 at-home tests on 13May, one on 15May, and another on 16May. Started experiencing sore throat, hoarse voice and cough on 26May2022. Tested positive with two different brand at-home tests on 27May2022. Not recovered. No treatment.
Severe RUQ pain of unknown etiology building in intensity from 8pm on 1/12 through 1/13.
Acute onset of Tachycardia 120-130  and SOA six hours post second vaccine sustained for  11 hours initially.  Arrhythmias and  SOA  continue with events ranging from seconds to hours.  Tachycardia, Burst of PVCs Resting HR normal is 50-60s  now in 80s a high percentage of the time. Slight blurry vision but has improved.
Lightheadedness and exhaustion set in 15-25 minutes post injection. Later that same evening, experienced nausea, muscle, bone, and joint aches as well as chest pain that were much reduced by the following morning. Malaise continued as did symptoms of nausea without vomiting.  24 hours post injection, experienced a low grade fever of 99.6 F (for me, this is a low grade temp). Fever broke after another 24 hours.  Experienced severe headaches in the middle of the forehead for 8-12 hours on 3/25/2021, 3/29/2021, 4/3/2021.  Experienced difficulty breathing 3/30/2021. Woke up from deep sleep feeling starved for oxygen and a sensation that a deep enough breath could not be taken--the lungs could  not expand enough. Respiratory rate seemed slightly depressed. It passed after about 30 minutes with focused effort on taking deep, regular breaths. Fell asleep again and did not consult a medical provider about it. The oxygen hunger / breathing issue did not repeat.  Medical professionals were not consulted for any of the episodes described above.
This case was reported by a nurse via sales rep and described the occurrence of white blood cell count low in a 1-year-old female patient who received MENHIBRIX. Concomitant product included PEDIARIX. On an unknown date, the patient received MENHIBRIX. On an unknown date, an unknown time after receiving MENHIBRIX, the patient experienced white blood cell count low. On an unknown date, the outcome of the white blood cell count low was unknown. It was unknown if the reporter considered the white blood cell count low to be related to MENHIBRIX. Additional details were provided as follows: This case was reported by field representative on behalf of a nurse. The patient also received PEDIARIX at the time of vaccination with MENHIBRIX.
Information has been received from a registered pharmacist concerning a 66 year old female with allergies to Ibuprofen and CEFTIN who on 26-FEB-2009 was subcutaneously vaccinated with the first 0.65 ml dose of ZOSTAVAX (Merck) (lot #663672/1709X). On 28-FEB-2009 the patient developed shingles rash on her lower abdomen and back. It was noted that the patient was placed on antiviral therapy to treat the shingles. She did not recover at the time of reporting. The patient was seen by the physician for medical attention. Follow up information was received from the pharmacist and physician who reported that the patient was seen by the physician because she had a reaction since the shingles vaccine was given at the pharmacy on 26-Feb-2009. On 28-Feb-2009 she started having a little bit of burning pain on the right lower aspect of her abdomen. As of report, she had a rash with blistering that came out on 02-MAR-2009 and it seemed to be extending around towards the back. Otherwise no fevers, chills or sweats. She felt kind of tired, though no specific complains. Vital signs were listed that the patient's weight was 183 and blood pressure was 128/72. Exam revealed on the L1 dermatome, or in the vicinity on her right side, a patch of erythema, old blisters. On the anterior aspect of the abdomen, right lower quadrant, extension around with some patchy similar lesions toward the back, not crossing the midline. No sign of superinfection. Assessment was that of shingles, zoster outbreak following the injection of the vaccine. In central, the patient noted she might have had chickenpox as a child, although all 3 of her children were exposed it was presumed she was exposed as well. The patient was given VALTREX 1000 mg, tid, for 7 day. She was recommended keeping the area clean and watching for signs of infection. Cortisone for itch, if necessary. She was instructed to contact the physician if her symptoms did not improve or worsened. The outcome was not reported. Additional information has been requested.
Information was received 25-JUL-2016 regarding a case in litigation for GARDASIL from a lawyer and the mother of a 15 year old girl (see case # 1503USA006173, same reporter and case # 1607USA010910, same reporter). The mother reported that she began to explore the internet and found many mothers who had similar problems when their daughters were given GARDASIL. Additional information is not expected
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 06-JUN-2013 the patient was vaccinated with GARDASIL, first dose. On 17-JUL-2013 the patient was vaccinated with GARDASIL, second dose. On 02-JAN-2014 the patient was vaccinated with GARDASIL, third dose. Pharmacist reported that the patient received an expired dose of GARDASIL on 02-JAN-2014 that was expired on 02-DEC-2013. No adverse effects reported. Additional information has been requested.
"Does not feel right", felt cold, tachycardia (114/min). No pruritis or rash. No respiratory distress.  Afebrile. Gave Acetaminophen extra strength 1000 mg and Diphenhydramine 25 mg IM. Follow-up on 6/17/13 now with erythema and pruritis at site of injection, left deltoid.
Information has been received from a female consumer with no pertinent medical history, drug reactions or allergies who "about 6 months ago", in approximately June 2007, was vaccinated with ZOSTAVAX.  Concomitant therapy included rosuvastatin calcium (CRESTOR), alendronate sodium (FOSAMAX) and atenolol.  In June 2007, the patient developed warmth and redness at injection site "right after" receiving ZOSTAVAX.  On an unspecified date "the area scabbed over and was about the size of a fingernail".  On an undisclosed date the scab fell off and "the area left was scarred and rough".  On 30 JUN 2008 the patient reported that "the area" was discolored, "white".  There were no lab diagnostic studies performed.  Unspecified medical attention was sought.  There was no product quality complaint.  Additional information has been requested. Follow up information has been received from a health professional concerning a 81 year old female with hyperlipidemia, anemia, and osteoporosis who on 28 AUG 2007, was vaccinated subcutaneously into the left arm with a first dose of ZOSTAVAX (Merck) (Lot # 657765/0585U). There was no illness at the time of vaccination. It was reported that "within one week of injection" the patient developed a hard white lump with red around it". The patient was seen by a dermatologist who "scraped tissue and froze it with nitrogen". The patient reported that she was left with a scar. At the time of reporting the patient had not yet recovered. Additional information has been requested.
My daughter was given shots for no reasons. They were duplicate shots and had not signed a release for these shots. This would not had happened if I had been consulted.
This spontaneous report was received from a registered nurse via medical assistant and refers to a 12-month-old male patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, past drugs and drug allergies were not reported. On 03-OCT-2017, the patient was vaccinated with improperly stored M-M-R II (lot # M034387; expiry date: 19-JUL-2018) (dosing details were not provided) for prophylaxis. Temperature excursion details of the vaccine were not provided. This is one of the several reports received from the same source. Sender's Comments: US-009507513-1709USA008861: US-009507513-1710USA013424: US-009507513-1710USA013470: US-009507513-1710USA013465: US-009507513-1710USA013440: US-009507513-1710USA013468: US-009507513-1710USA013442: US-009507513-1710USA013445: US-009507513-1710USA013460: US-009507513-1710USA013463: US-009507513-1710USA013464: US-009507513-1710USA013438: US-009507513-1710USA013439: US-009507513-1710USA013450: US-009507513-1710USA013430: US-009507513-1710USA013469: US-009507513-1710USA013467: US-009507513-1710USA013435: US-009507513-1710USA013434: US-009507513-1710USA013432: US-009507513-1710USA013428: US-009507513-1710USA013437: US-009507513-1710USA013441: US-009507513-1710USA013443: US-009507513-1710USA013444: US-009507513-1710USA013446: US-009507513-1710USA013447: US-009507513-1710USA013448: US-009507513-1710USA013436: US-009507513-1710USA013449: US-009507513-1710USA013451: US-009507513-1710USA013452: US-009507513-1710USA013454: US-009507513-1710USA013455: US-009507513-1710USA013456: US-009507513-1710USA013457: US-009507513-1710USA013458: US-009507513-1710USA013459:  US-009507513-1710USA013461: US-009507513-1710USA013462: US-009507513-1710USA013466: US-009507513-1710USA013427: US-009507513-1710USA013471: US-009507513-1710USA013472: US-009507513-1710USA013473: US-009507513-1710USA013474: US-009507513-1710USA013475: US-009507513-1710USA013476: US-009507513-1710USA013425: US-009507513-1710USA013433: US-009507513-1710USA013423: US-009507513-1710USA013040: US-009507513-1710USA013426: US-009507513-1710USA013429: US-009507513-1710USA013431: US-009507513-1709USA008666: Original Case: 1709USA008666: US-009507513-1710USA014650: Original Case: 1710USA014649: US-009507513-1710USA014651: Original Case: 1710USA014649: US-009507513-1710USA014649: Original Case: 1710USA014649.
He started to be disoriented while I (daughter) was driving the car. He thought we were in Fort Lauderdale. When we got home he said he was disoriented and did not remember the month we were or the name of our dog. He was checking the phone saying he did never send the messages that were sent by him some minutes ago and did not remember the conversations he had in the morning. He never have had problems like this and we were very surprised. He rested a bit and the disorientation stop about an hour later. He is now feeling fine. My aunt, who is an MD said he should take a cardio aspirin and that's what he did. His blood pressure and temperature were always well. As a reference, he had COVID in March 2020 and was hospitalized due to it but recovered well. He then received the first covid dose in March 19, 2021 and had some fever, chills, and headache but was otherwise fine.
facial hives, lasted 3 days. Rash on the arm, tachycardia (persisted 2 weeks plus), increased memory problems, increased fatigue, increased dyspnea (did have Covid infection 11/2020)
within 24 hours develop significant lymphadenopathy right groin that got worse after 2nd dose and now presents to clinic with large firm lymph node rt groin with obstruction of venous system in rt lower leg with entire rt lower leg edema and redness. patients transferred to local Emergency department.
This event was not an adverse event, however, it was an invalid dose because the patient was less than 18 years of age when she received her first dose of the Moderna COVID vaccine. Patient did state she experienced some light dizziness about 5 minutes after she was given the vaccine and that this has happened before with the influenza vaccine. She also stated that she did not have anything to eat or drink at all that morning so she may have been experiencing weakness from that as well.  It resolved within 10-15 minutes and patient was fine to go home per other healthcare providers.
I developed severely blotchy skin on my inner right thigh on Friday evening (5/28/21).  It would not clear up and was subcutaneous (not chafing).  It was a little sore to the touch in places.  I did a Google search and was alarmed when one of the first things to pop up was possible clotting.  I had also been experiencing strange heart fluttering/palpitations and my chest felt tight, like I couldn't take a deep breath comfortably.  My husband brought home some chewable low dose aspirin.  I took approx. 600mg (per directions - it said take 4-8 tablets every 4 hours).  I took 8 tablets.  Within 15 minutes the blotchiness started to fade in my leg, and within on hour it was 90% better.  It was 100% better by the next morning.  I have since been taking one low dose aspirin per day as a precaution.  Heart palpitations also stopped with the aspirin.  I emailed my doctor at the time of the event but have not heard back, as it was a holiday weekend.  I chose not to go to the ER since the symptoms subsided, but I still worry and plan to see my doctor about this event.  The heart palpitations were NOT a tachycardia event.  I am all too familiar, and this was entirely different with chest tightness also noted.
Healthcare facility told pt to call and report that after taking the first shot he stop having seizures. Before getting the shot he was having multi seizures a day or at least 2 a week and now after the shot he hasn't had any.
Approx 238PM pt can not see; mom helsp to chair; aunt pale in colr; pt lying on floor; feet elevated BP/90/60; skin cool, clammy;
Myalgia, Arthralgia, Fever, NauseaVomiting, ear discomfort Narrative: Pt reported the following ADRs post 2nd covid vaccine: fever, myalgia, arthralgia, ear discomfort, nausea. Pt reliveved with 400mg ibuprofen oral.
Day 1-3- Sore Arm Day 4- Severe nausea and dizziness, had to request a ride home from work and leave early. Day 5- Severe nausea and dizziness followed by fever and chills, was only at work for an hour before having to leave Day 6- Severe Abdominal pain followed by diarrhea and vomitting and also a temperature hovering around 101.4, took OTC nausea med and made it through most of the work day. Become very nauseated and dizzy and had to leave early. Day 7- Became very disoriented and nauseated, left work for urgent care where initial BP reading was 189/123. Slowly dropped to 153/114 (took a covid test and results were negative, also had blood drawn) Day 8- Stayed home from work and felt fine as long as I was sitting/laying and stationary. Immediate dizzy spells and disorientation upon standing
vaccine in the afternoon. Woke with with headache, sore throat and nausea. Unknown vaccine site and manufac.
This case was reported by a pharmacist via call center representative and described the occurrence of blister in a 71-year-old male patient who received SHINGRIX (batch number EH9Z7, expiry date 8th March 2021) for prophylaxis. On 17th October 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 20th October 2018, 3 days after receiving SHINGRIX, the patient experienced blister. On an unknown date, the outcome of the blister was not recovered/not resolved. It was unknown if the reporter considered the blister to be related to SHINGRIX. Additional details were provided as follows: On Wednesday at 11:30 am, the patient received SHINGRIX on the left deltoid and by Saturday the patient had puss like blisters on his chest. Initially there were 6 to 7 blisters and at the time of reporting there was a patch of blisters.
4/19/07 after HPV (Cardasil) 2 doses patient feel dizzy even laying down BP = 85/50, At 1:30 pm patient BP = 90/60 Still dizzy when standing up, still with leg elevated increase receive fluid juice at 1:48 pm, BP 95/60 improving, left walking with her mother. Patient 16 years old arrive to my office at 12: 22 pm. In 4/19/2007 for the second doses of Gardasil (HPV) Vaccine. The First dose was given in 02/19/2007 with no side effects. Because I received information of 500 cases  of fainting spell I always place my patients on her back to prevent any fainting spells but even in this position Patient develop dizziness spells after around 10 mins after the injection of Gardasil, check the BP and was 85/50 and weak pulse, sitting up develop dizziness spells and not feeling well. At 1:30 pm BP = 90/60 persist dizziness spell and unable to stand up; receive juice by mouth at 1:48 pm. And recheck the BP=95/60 no more dizziness spells, no nausea left with her mother walking. At 1:50 pm call Regional Director of the Health Department unavailable , left message with detail of the event. 04/20/2007 at 8:25 am Dr left in my answering machine the information that patient must not receive the 3rd doses of Gardasil. 04/20/2007 at 8:36 call mother of patient informed me the report of Dr and advice do not receive the 3rd dose of Gardasil because of severe reaction may be happen understood mother inform that patient yesterday after left my office went to sleep and feel a hot burning sensation inside her body and today 04/20/2007 patient went to school
Diffuse hives developed 1 day after vaccine administration. Parents also report facial swelling.
Patient received partial dose; started to develop red, raised rash areas on face while giving vaccine. Administration stopped by nurse, Dr. was immediately informed of reaction and evaluated patient.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 22-year-old male patient received BNT162b2 (BNT162B2), on 09Apr2021 as dose number unknown, single (Lot number: ER8731), in left arm and on 03Jun2021 as dose number unknown, single (Lot number: EW0175) at the age of 21 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 11Dec2021 as dose number unknown, single (Lot number: 060H21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Apendicitus" (unspecified if ongoing); "Pericarditis" (unspecified if ongoing); "vaccine brand=Pfizer / BioNTech;vaccine brand other=Moderna" (unspecified if ongoing), notes: vaccine brand=Pfizer / BioNTech,, vaccine brand other=Moderna. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of suspected covid-19.Clinical Course : Was the patient taking any other medications/products within 2 weeks of starting COVID-19 treatment was reported as no. the patient previously receive a COVID-19 Vaccine was reported as Yes. Known allergies was reported as no. Anti-viral details: product COVID 19 Treatment, brand Paxlovid, treatment start date 12May2022, treatment stop date May2022, indication Treatment of COVID-19.  Follow-up attempts are completed. No further information is expected.
Dizzy and nauseous upon vaccination.  Fatigue, headache,  malaise,  muscle aches from 2/28/2021 to present 3/9/2021
Swelling of the lips, face, genitals, and throat and hives on various body part  This has lasted over 30 days.
A week after injection, armed turned red around injection site , itched, & a rash formed.  Still there a week later.  No pain or soreness now although I did have a little for several day after injection.